236 related articles for article (PubMed ID: 24294303)
1. Clinical experience with duloxetine in the management of chronic musculoskeletal pain. A focus on osteoarthritis of the knee.
Brown JP; Boulay LJ
Ther Adv Musculoskelet Dis; 2013 Dec; 5(6):291-304. PubMed ID: 24294303
[TBL] [Abstract][Full Text] [Related]
2. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.
Pergolizzi JV; Raffa RB; Taylor R; Rodriguez G; Nalamachu S; Langley P
Pain Pract; 2013 Mar; 13(3):239-52. PubMed ID: 22716295
[TBL] [Abstract][Full Text] [Related]
3. Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial.
Chappell AS; Ossanna MJ; Liu-Seifert H; Iyengar S; Skljarevski V; Li LC; Bennett RM; Collins H
Pain; 2009 Dec; 146(3):253-260. PubMed ID: 19625125
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia.
Lunn MP; Hughes RA; Wiffen PJ
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD007115. PubMed ID: 24385423
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of duloxetine in patients with chronic low back pain.
Skljarevski V; Desaiah D; Liu-Seifert H; Zhang Q; Chappell AS; Detke MJ; Iyengar S; Atkinson JH; Backonja M
Spine (Phila Pa 1976); 2010 Jun; 35(13):E578-85. PubMed ID: 20461028
[TBL] [Abstract][Full Text] [Related]
6. Profile of adverse events with duloxetine treatment: a pooled analysis of placebo-controlled studies.
Brunton S; Wang F; Edwards SB; Crucitti AS; Ossanna MJ; Walker DJ; Robinson MJ
Drug Saf; 2010 May; 33(5):393-407. PubMed ID: 20397739
[TBL] [Abstract][Full Text] [Related]
7. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
Welsch P; Üçeyler N; Klose P; Walitt B; Häuser W
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD010292. PubMed ID: 29489029
[TBL] [Abstract][Full Text] [Related]
8. Duloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: results of a randomized, double-blind, placebo-controlled trial.
Frakes EP; Risser RC; Ball TD; Hochberg MC; Wohlreich MM
Curr Med Res Opin; 2011 Dec; 27(12):2361-72. PubMed ID: 22017192
[TBL] [Abstract][Full Text] [Related]
9. A mechanism-based proof of concept study on the effects of duloxetine in patients with painful knee osteoarthritis.
Ammitzbøll N; Arendt-Nielsen L; Bertoli D; Brock C; Olesen AE; Kappel A; Drewes AM; Petersen KK
Trials; 2021 Dec; 22(1):958. PubMed ID: 34961547
[TBL] [Abstract][Full Text] [Related]
10. Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy.
Wright A; Luedtke KE; Vandenberg C
J Pain Res; 2010 Dec; 4():1-10. PubMed ID: 21386950
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine Reduces Pain and Improves Quality of Recovery Following Total Knee Arthroplasty in Centrally Sensitized Patients: A Prospective, Randomized Controlled Study.
Koh IJ; Kim MS; Sohn S; Song KY; Choi NY; In Y
J Bone Joint Surg Am; 2019 Jan; 101(1):64-73. PubMed ID: 30601417
[TBL] [Abstract][Full Text] [Related]
12. Duloxetine in the management of diabetic peripheral neuropathic pain.
Ormseth MJ; Scholz BA; Boomershine CS
Patient Prefer Adherence; 2011; 5():343-56. PubMed ID: 21845034
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.
Wernicke JF; Pritchett YL; D'Souza DN; Waninger A; Tran P; Iyengar S; Raskin J
Neurology; 2006 Oct; 67(8):1411-20. PubMed ID: 17060567
[TBL] [Abstract][Full Text] [Related]
14. Duloxetine for treating painful neuropathy or chronic pain.
Lunn MP; Hughes RA; Wiffen PJ
Cochrane Database Syst Rev; 2009 Oct; (4):CD007115. PubMed ID: 19821395
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial.
Upadhyaya HP; Arnold LM; Alaka K; Qiao M; Williams D; Mehta R
Pediatr Rheumatol Online J; 2019 May; 17(1):27. PubMed ID: 31138224
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of duloxetine for chronic pain conditions.
Mease PJ; Walker DJ; Alaka K
Pain Manag; 2011 Mar; 1(2):159-70. PubMed ID: 24646356
[TBL] [Abstract][Full Text] [Related]
17. The effect of duloxetine on mechanistic pain profiles, cognitive factors and clinical pain in patients with painful knee osteoarthritis-A randomized, double-blind, placebo-controlled, crossover study.
Petersen KK; Drewes AM; Olesen AE; Ammitzbøll N; Bertoli D; Brock C; Arendt-Nielsen L
Eur J Pain; 2022 Sep; 26(8):1650-1664. PubMed ID: 35638317
[TBL] [Abstract][Full Text] [Related]
18. Review of duloxetine in the management of diabetic peripheral neuropathic pain.
Smith T; Nicholson RA
Vasc Health Risk Manag; 2007; 3(6):833-44. PubMed ID: 18200804
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.
Raskin J; Pritchett YL; Wang F; D'Souza DN; Waninger AL; Iyengar S; Wernicke JF
Pain Med; 2005; 6(5):346-56. PubMed ID: 16266355
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
